- Home
- RVMD vs HUM Comparison
RVMD vs HUM Comparison
Compare RVMD & HUM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RVMD | HUM |
|---|---|---|
| Founded | 2014 | 1961 |
| Country | United States | United States |
| Employees | 883 | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Medical Specialities |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 19.2B | 22.5B |
| IPO Year | N/A | 2002 |
Fundamental Metrics
Financial Performance| Metric | RVMD | HUM |
|---|---|---|
| Price | $96.36 | $192.29 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 17 | 20 |
| Target Price | $120.47 | ★ $237.65 |
| AVG Volume (30 Days) | ★ 1.6M | 1.5M |
| Earning Date | 05-06-2026 | 04-29-2026 |
| Dividend Yield | N/A | ★ 1.79% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 9.84 |
| Revenue | N/A | ★ $129,664,000,000.00 |
| Revenue This Year | N/A | $25.34 |
| Revenue Next Year | $411.49 | $6.11 |
| P/E Ratio | ★ N/A | $20.15 |
| Revenue Growth | N/A | ★ 10.11 |
| 52 Week Low | $34.00 | $163.11 |
| 52 Week High | $124.49 | $315.35 |
Technical Indicators
Market Signals| Indicator | RVMD | HUM |
|---|---|---|
| Relative Strength Index (RSI) | 48.24 | 59.57 |
| Support Level | $93.39 | $186.00 |
| Resistance Level | $101.00 | $285.02 |
| Average True Range (ATR) | 3.12 | 6.88 |
| MACD | 0.21 | 3.95 |
| Stochastic Oscillator | 51.05 | 71.26 |
Price Performance
Historical ComparisonAbout RVMD Revolution Medicines Inc.
Revolution Medicines Inc is a clinical-stage precision oncology company developing novel targeted therapies for RAS-addicted cancers. The Company possesses structure-based drug discovery capabilities built upon chemical biology and cancer pharmacology know-how and proprietary technologies that enable the creation of small molecules tailored to unconventional binding sites. Its research and development pipeline comprises inhibitors that bind directly to RAS variants (RAS(ON) Inhibitors), designed to be used as monotherapy, in combination with other RAS(ON) Inhibitors and/or other therapeutic agents.
About HUM Humana Inc.
Humana is one of the largest private health insurers in the US, and the firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from Medicare, Medicaid, and the military's Tricare program. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.